The assessment encompassed a range of immune cells including B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and dendritic cells to obtain a comprehensive understanding of the impact of each gene on the tumor microenvironment. This evidence concerns the gene CD8A and neoplasm.